KOMIPHARM INTERNATIONAL CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 041960 for the last quarter is 10.99 B KRW, and it's 42.62% lower compared to the previous quarter. The net income of Q3 24 is 6.49 B KRW.